Locations:
Search IconSearch

Prioritizing Function Over Pills and Procedures for Chronic Low Back Pain

New pilot program aims to remake the management model

Prioritizing Function Over Pills and Procedures for Chronic Low Back Pain

Value-based care and the opioid epidemic don’t usually come up in the same sentence, but they have at least one thing in common: Both were high on the list of 2016’s healthcare headlines.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Over the past year, Cleveland Clinic’s Neurological Institute has given these issues another point of intersection with a bold new initiative to promote value-based care for patients with chronic pain while also preventing inappropriate opioid use.

The initiative, launched in August 2016 and detailed in an earlier post, is a population health pilot program to treat more than 1,000 patients with chronic low back and leg pain by prioritizing functional outcomes over opioid- or procedure-based care. If successful, the model can be applied to other chronic pain conditions and perhaps replicated at other institutions.

Eligible patients are those with low back or leg pain for more than three months. All patients undergo combined physical and behavioral pain rehabilitation as the first line of care, specifically:

  • Counseling from a behavioral medicine specialist in pain plus group therapy sessions that focus on behavioral strategies to manage pain, as detailed here
  • Physical therapy in individual and group sessions, with an emphasis on functional rehabilitation, as detailed here

The aim is to promote pain rehabilitation by managing the sensory, cognitive and affective domains of pain. The key outcome metric is restoration of function. “It’s about delivering real value to patients, with a meaningful transformation of their lives, rather than hoping for a quick fix,” says Neurological Institute Chair Andre Machado, MD, PhD.

Spine medicine physicians and spine surgeons are available throughout patients’ longitudinal care. They manage medications, order tests and provide surgical evaluations when appropriate.

Advertisement

“Patients will not be denied surgery, procedures or pain medications if the diagnosis calls for such,” explains spine neurosurgeon Edward Benzel, MD, founder of Cleveland Clinic’s Center for Spine Health. “We emphasize that surgery is deemed appropriate only after all other relevant and safer treatment strategies have been considered or tried.”

The program is expected to achieve its primary goal of helping patients recover function and become active again while also achieving:

  • Avoidance of opioid prescriptions for chronic pain
  • Greater prudence in prescribing
  • Greater patient empowerment to self-manage and control pain

The program is highly interdisciplinary, with leadership from the Neurological Institute’s Center for Spine Health, Department of Physical Medicine and Rehabilitation, Center for Neurological Restoration and Center for Behavioral Health.

“The literature supports a collaborative approach to these patients,” says Mary Stilphen, PT, DPT, Senior Director of Rehabilitation and Sports Therapy. “Single approaches, utilized in isolation, are often unsuccessful.”

“Pain is a multifaceted experience that demands interdisciplinary collaboration,” adds Sara Davin, PsyD, MPH. “This program differs from others in its interdisciplinary approach to care. Team members from multiple disciplines come together for an end result that’s greater than the sum of its parts.”

“This project is made possible by the Neurological Institute’s distinctive organizational structure, which breaks down departmental barriers to promote collaboration across subspecialties,” notes Dr. Machado. “Pulling this off in a traditional model would be difficult.”

Advertisement

Related Articles

23-NEU-3516858-brain-trauma-650×450
Neurotrauma Guidelines: Where They’ve Been, Where They’re Headed and How to Make the Most of Them

Q&A with Brain Trauma Foundation guideline architect Gregory Hawryluk, MD, PhD

20-NEU-2020111 neuroimmunology_650x450
Autoimmune Neurologic Disorders: Treatable Conditions That Should Not Be Missed

Q&A with newly arrived autoimmune neurology specialist Amy Kunchok, MD

20-NEU-1984276 multimodal-monitoring_650x450
Multimodal Monitoring in the Neuro ICU: Essentials for Clinicians (Podcast)

A neurocritical care specialist shares what’s spurring growth of this new evaluation approach

central vein sign in multiple sclerosis
New Frontiers in Diagnosing and Monitoring Multiple Sclerosis (Podcast)

Get ready for central vein sign and optical coherence tomography

20-NEU-1938374-migraine_650x450
CGRP Antagonists for Decreasing Migraine Frequency: A Primer

How these new drugs fit into practice two years out from their first approvals

20-NEU-1892171 CQD_650x450_CCC-1901608_06-03-20_0443
What’s Afoot and What’s Ahead for Physical Medicine and Rehabilitation

A conversation on the state of physiatry with the AAPM&R’s Vice President

Ad